19 results
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
, Sustainable Long-Term Growth Closing Remarks Q&A
PROPRIETARY AND CONFIDENTIAL Q1 2024 Update Transformation Plan Update Joseph C. Papa President and Chief … % of Revenue Weighted avg. fully diluted share count ~52 Capex ~$32 Depreciation & amortization ~$111
Driving Profitable, Sustainable Long- Term
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
4:05pm
.
"Today’s actions are about the future of Emergent,” said CEO Joe Papa. “We have put in place a multi-year plan to position Emergent for sustainable
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
furthers our ability to execute on our strategy to stabilize and strengthen our core business and position Emergent for sustainable long-term growth … and build the foundation for sustainable, long-term growth,” said Emergent CFO Richard S. Lindahl. “Working constructively with our bank group, we have now
8-K
EX-99.1
08yfv9
9 May 23
Emergent Biosolutions Reports Financial Results for First Quarter 2023
4:05pm
8-K
EX-99.2
fyw8kv r2rq94iim9
9 May 23
Emergent Biosolutions Reports Financial Results for First Quarter 2023
4:05pm
DEFR14A
qs7jp85p2vp0m6
24 Apr 23
Revised proxy
9:32am
8-K
EX-99
c4losrwwa38pvqv0gzc1
25 May 21
Departure of Directors or Certain Officers
4:59pm
8-K
EX-99.2
dlq1ol p0bs
11 Jan 21
Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results
6:34am
8-K
EX-99.2
ngnot5gft5q5cwn2
13 Jan 20
Emergent Biosolutions Announces Preliminary 2019 Financial Results and Provides 2020 Financial Forecast
6:43am
8-K
EX-99
acn7nh9mqcl
4 Sep 19
Entry into a Material Definitive Agreement
9:26am
- Prev
- 1
- Next